Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction

Published:2015-08-26 Issue:1 Volume:26 Page:4-20
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev. Med. Virol.

Author:

Fumakia Miral¹,Yang Sidi¹,Gu Jijin¹,Ho Emmanuel A.¹^ORCID

Affiliation:

1. Laboratory for Drug Delivery and Biomaterials, College of Pharmacy, Faculty of Health Sciences; University of Manitoba; Winnipeg MB Canada

Funder

Canadian Institutes of Health Research

Research Manitoba

University of Manitoba Graduate Fellowship

Research Manitoba Graduate Studentship

Research Manitoba Post-Doctoral Fellowship

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference174 articles.

1. UNAIDS 2013 UNAIDS report on the global AIDS epidemic 2013

2. UNAIDS A strategic approach to HIV and education 2009

3. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review;McMahon;Bulletin of the World Health Organization,2013

4. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel;Thompson;JAMA,2010

5. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART;Hogg;PLoS Medicine,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced molecular mechanisms of modified DRV compounds in targeting HIV-1 protease mutations and interrupting monomer dimerization;Physical Chemistry Chemical Physics;2024

2. Functional expression of Escherichia coli-derived recombinant plastocyanin from Canna indica L. and its anti-HIV-1 activities;ScienceAsia;2023

3. Endogenous Peptide Inhibitors of HIV Entry;Advances in Experimental Medicine and Biology;2022

4. Multiple Molecular Dynamics Simulations and Free-Energy Predictions Uncover the Susceptibility of Variants of HIV-1 Protease against Inhibitors Darunavir and KNI-1657;Langmuir;2021-12-01

5. A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region;Journal of Medicinal Chemistry;2021-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3